P414: RNA MODIFICATION-FOCUSED CRISPR-CAS9 SCREEN REVEALS POTENTIAL THERAPEUTIC TARGETS MEDIATING CHEMORESISTANCE IN AML

• M. Kienhöfer,
• C. Pauli,
• S. Delaunay,
• C. Rohde,
• M. F. Blank,
• D. Heid,
• M. Frye,
• C. Müller-Tidow

Affiliations

M. Kienhöfer

1 Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg

C. Pauli

1 Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg

S. Delaunay

2 German Cancer Research Center (DKFZ)

C. Rohde

1 Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg

M. F. Blank

1 Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg

D. Heid

1 Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg

M. Frye

2 German Cancer Research Center (DKFZ)

C. Müller-Tidow

1 Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg